"Many medicinal agents important to life are combinations of mirror-image twins. Despite the
close resemblance of such twins, the differences in their biological properties can be profound.
In other words the component enantiomers of a racemic chiral drug may differ wildly in their
pharmacokinetic, pharmacodynamic profile. The tragedy of thalidomide illustrates the potential
for extreme consequences"...
Read more @ the following articles.
Links to some more publications in the area of drug chirality are given below. These articles and references therein might be of interest to readers.